Gastric cancer, version 3.2016: NCCN Clinical Practice Guidelines in Oncology Journal Article


Authors: Ajani, J. A.; D'Amico, T. A.; Almhanna, K.; Bentrem, D. J.; Chao, J.; Das, P.; Denlinger, C. S.; Fanta, P.; Farjah, F.; Fuchs, C. S.; Gerdes, H.; Gibson, M.; Glasgow, R. E.; Hayman, J. A.; Hochwald, S.; Hofstetter, W. L.; Ilson, D. H.; Jaroszewski, D.; Johung, K. L.; Keswani, R. N.; Kleinberg, L. R.; Korn, W. M.; Leong, S.; Linn, C.; Lockhart, A. C.; Ly, Q. P.; Mulcahy, M. F.; Orringer, M. B.; Perry, K. A.; Poultsides, G. A.; Scott, W. J.; Strong, V. E.; Washington, M. K.; Weksler, B.; Willett, C. G.; Wright, C. D.; Zelman, D.; McMillian, N.; Sundar, H.
Article Title: Gastric cancer, version 3.2016: NCCN Clinical Practice Guidelines in Oncology
Abstract: Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of death from cancer in the world. Several advances have been made in the staging procedures, imaging techniques, and treatment approaches. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer provide an evidence- and consensus-based treatment approach for the management of patients with gastric cancer. This manuscript discusses the recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease. © National Comprehensive Cancer Network, Inc. 2016, All rights reserved.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 14
Issue: 10
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2016-10-01
Start Page: 1286
End Page: 1312
Language: English
PROVIDER: scopus
PUBMED: 27697982
DOI/URL:
Notes: Review -- Export Date: 2 November 2016 -- Source: Scopus
Citation Impact
MSK Authors
  1. Hans Gerdes
    176 Gerdes
  2. Vivian Strong
    264 Strong
  3. David H Ilson
    433 Ilson
Related MSK Work